Alpha1-proteinase inhibitor
471201
Approved mab completed
Quick answer
Alpha1-proteinase inhibitor for Alpha1-antitrypsin Deficiency is a Approved program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Alpha1-antitrypsin Deficiency
- Phase
- Approved
- Modality
- mab
- Status
- completed